hat
Mesterolone te sentèz ak prezante pou itilize medikal an 1934 e li te AAS nan premye yo dwe commercialisés. Li te swiv pa methyltestosterone nan 1936 ak propionate testostewòn nan 1937. Dwòg la kontinye ap lajman disponib ak itilize jodi a. Mesterolone se yon esteroyetik ak oral aktif anabolik-Androjenik esteroyid (AAS) ak yon derive nan dihydrotestosterone (DHT) .Li se dekri kòm yon AAS relativman fèb ak raman itilize nan bi pou terapi ranplasman android, men se toujou lajman itilize. Li vann anba mak Non Proviron nan mitan lòt moun.
eng
Mesterolone was synthesized and introduced for medical use in 1934 and was the first AAS to be marketed. It was followed by methyltestosterone in 1936 and testosterone propionate in 1937. The drug continues to be widely available and used today. Mesterolone is a synthetic and orally active anabolic–androgenic steroid (AAS) and a derivative of dihydrotestosterone (DHT).It is described as a relatively weak AAS and is rarely used for the purpose of androgen replacement therapy, but is still widely used. It is sold under the brand name Proviron among others.